Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04737239 · ClinicalTrials.gov registry record
Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies
A clinical trial of Carpal Tunnel Syndrome, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04737239 is a study of Carpal Tunnel Syndrome that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 300 participants, above the 208-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04737239, a study of Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Carpal Tunnel Syndrome (CTS) is the most common nerve entrapment syndrome worldwide. There are currently no studies examining the effectiveness of corticosteroid injections in patients with normal (negative) EMG studies. The purpose of this study is to gain a better understanding of the duration of symptom improvement post corticosteroid injection in patients with negative or mild EMG studies. The Boston Carpal Tunnel Questionnaire will be given to patients undergoing corticosteroid injections for the treatment of carpal tunnel syndrome to assess their response to the injection. Investigators will collect data retrospectively. The Boston Carpal Tunnel Questionnaire (BCTQ) is administered as per standard protocol to all patients with CTS who have a negative or mild EMG study. The BCTQ assesses the patient's self-reported symptom severity and functional status. Investigators will analyze this data with respect to demographics as well as numbness in the median n. distribution, nocturnal numbness, weakness/atrophy of the thenar musculature, Tinel's sign, Phalen's test, loss of 2-point discrimination, Quick-Dash score, and grip strength score. The primary outcome will be the Boston Carpal Tunnel Questionnaire outcome score under the different EMG conditions.The secondary outcomes will be numbness in the median n. distribution, nocturnal numbness, weakness/atrophy of the thenar musculature, Tinel's sign, Phalen's test, loss of 2-point discrimination, QuickDash score, and grip strength score. Both outcomes will be examined in patients with negative or mild EMG readings. This information will allow orthopedic physicians to gain a better understanding of the duration of symptom improvement post-corticosteroid injection, allowing them to fine tune their treatment plans for CTS patients.
Conditions Studied
Interventions
- OTHER Corticosteroid injections for CTS treatment
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2026-12-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04737239
The ClinicalTrials.gov registry entry for NCT04737239 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 208-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (44% higher). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Corticosteroid injections for CTS treatment is the first listed.
NCT04737239 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04737239 about?
NCT04737239 is a clinical study titled "Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies". Carpal Tunnel Syndrome (CTS) is the most common nerve entrapment syndrome worldwide. There are currently no studies examining the effectiveness of corticosteroid injections in patients with normal (negative) EMG studies. The purpose of this study is to gain a better understanding of the duration of ...
What is the current status of trial NCT04737239?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-12-23. Estimated completion is 2026-12-22.
What conditions does trial NCT04737239 study?
This clinical trial studies the following conditions: Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT04737239?
The interventions under investigation include: Corticosteroid injections for CTS treatment (OTHER).
Who is sponsoring clinical trial NCT04737239?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04737239 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carpal Tunnel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Carpal Arch Space Augmentation (CASA) Clinical Trial
RECRUITING · NA
-
Ultrasound Analysis of Human Carpal Tunnel System
RECRUITING
-
Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
RECRUITING · NA
-
Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing
RECRUITING · NA
-
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
RECRUITING · NA
-
Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.